Submitted by Anonymous (not verified) on 12 April 2024 - 16:26
Human medicines European public assessment report (EPAR): Darzalex, daratumumab, Date of authorisation: 20/05/2016, Revision: 2, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Darzalex, daratumumab, Date of authorisation: 20/05/2016, Revision: 2, Status: Authorised